{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-113561","form_type":"8-K","ticker":"OSTX","cik":"0001795091","company_name":"OS Therapies Inc","filed_at":"2024-12-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.658003+00:00","generated_at":"2026-05-28T22:49:43.952766+00:00","sec_items":["1.01","3.02","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"OS Therapies announces $6M private placement; OST-HER2 Phase 2b data in Jan 2025","bullets":["Gross proceeds of $6M from sale of 1.5M units at $4.00/unit; each unit = 1 share Series A convertible preferred + 1 warrant.","Initial conversion price $4.00, warrant exercise price $4.40; prices subject to reset with floor of $1.00 and ceiling $4.00.","Proceeds to fund working capital and support commercialization of OST-HER2 for recurrent metastatic osteosarcoma.","Phase 2b trial data for OST-HER2 expected during week of JP Morgan Healthcare Conference in January 2025.","95% of investment from pre-IPO and/or IPO investors; $6M provides cash runway into 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-113561","json":"https://secwatch.observer/filing/0001213900-24-113561.json","markdown":"https://secwatch.observer/filing/0001213900-24-113561.md","text":"https://secwatch.observer/filing/0001213900-24-113561.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1795091/000121390024113561/0001213900-24-113561-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1795091/000121390024113561/ea0226258-8k_osthera.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T22:49:43.952766+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}